Synonyms: T-705 | T705
favipiravir is an approved drug (China and Japan)
Compound class:
Synthetic organic
Comment: Favipiravir (T-705) is an orally delivered, guanine (purine) analogue antiviral drug (cf. remdesivir which is administered i.v.). It targets viral RNA-dependent RNA polymerase (RdRP) of RNA viruses and since the catalytic domain of RdRP is well conserved across species, has a broad-spectrum of activity; although Furuta et al. (2002) reported that actvity was weak against non-influenza virus RNA viruses [4]. Favipiravir was originally identified through a chemical library screen against influenza virus RdRP [3]. Chemically, it is a prodrug. In human cells it undergoes phosphoribosylation and phosphorylation to its active form, favipiravir-ribofuranosyl-5′-triphosphate (F-RTP). F-RTP is bound by the RdRP, but it blocks enzyme activity and so terminates chain elongation [5-6].
|
|
Classification | |
Compound class | Synthetic organic |
Approved drug? | Yes (China and Japan) |
IUPAC Name |
5-fluoro-2-oxo-1H-pyrazine-3-carboxamide |
International Nonproprietary Names | |
INN number | INN |
8916 | favipiravir |
Synonyms |
T-705 | T705 |
Database Links | |
CAS Registry No. | 259793-96-9 (source: WHO INN record) |
ChEMBL Ligand | CHEMBL221722 |
DrugBank Ligand | DB12466 |
DrugCentral Ligand | 4887 |
GtoPdb PubChem SID | 434122199 |
PubChem CID | 492405 |
Search Google for chemical match using the InChIKey | ZCGNOVWYSGBHAU-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | ZCGNOVWYSGBHAU |
Search PubMed clinical trials | favipiravir |
Search PubMed titles | favipiravir |
Search PubMed titles/abstracts | favipiravir |
UniChem Compound Search for chemical match using the InChIKey | ZCGNOVWYSGBHAU-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | ZCGNOVWYSGBHAU-UHFFFAOYSA-N |